Cafepharma Today

June 3 2025 - Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Arrowhead commences dosing in Phase I/IIa obesity treatment trial
ASCO: Bristol Myers CMO brushes off LAG-3 concern in lung cancer after Opdualag's adjuvant melanoma flop
Amid staff cuts, FDA looks to AI to 'optimize' reviews
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Facet rejects Biogen Idec offer
Bizjournals.com
Thursday, December 10, 2009 - 10:30am
tags:
Facet Biotech, M&A, Biogen Idec
Drugmakers, Hospitals, Insurers Fight Changes to Health Bill
Bloomberg
Thursday, December 10, 2009 - 10:27am
tags:
healthcare bill, healthcare reform
How Gloucester Achieved the Impossible Even Before Inking the Celgene Deal
BNET Pharma
Thursday, December 10, 2009 - 10:26am
tags:
Celgene, Glouchester Pharma, M&A
Dendreon's New Stock Offering Takes Advantage of Provenge Decision Uncertainty
BNET Pharma
Thursday, December 10, 2009 - 10:25am
tags:
Provenge, Dendreon, stock offering
FDA Complete Response Letters & Transparency
Pharmalot
Thursday, December 10, 2009 - 10:24am
tags:
FDA, transparency
Lilly forecasts sidestep 2011-2014 patent cliff
Yahoo/Reuters
Thursday, December 10, 2009 - 8:56am
tags:
patents, Eli Lilly, earnings
AstraZeneca Explores Drugmaker Alliances to Spread Cost, Risks
Bloomberg
Thursday, December 10, 2009 - 8:44am
tags:
AstraZeneca, drug development, partnerships
SEC eyes 9 deals in insider trading probe: report
Yahoo/Reuters
Thursday, December 10, 2009 - 8:36am
tags:
Wyeth, SEC, Schering Plough, Pfizer, Merck, M&A, Eli Lilly, insider trading, Abbott Laboratories
Major Surgery at Sanofi
Businessweek
Thursday, December 10, 2009 - 8:34am
tags:
Sanofi, Chris Viehbacher, Pharma CEOs, M&A
Lilly Plans Two New Drugs a Year Starting in 2013, China Focus
Bloomberg
Thursday, December 10, 2009 - 7:54am
tags:
China, Eli Lilly, pipelines, Alzheimer's disease, diabetes, cancer
High Hopes Remain for Celgene's Revlimid
Seeking Alpha
Thursday, December 10, 2009 - 7:53am
tags:
Celgene, Revlimid, Multiple Myeloma
H1N1 Vaccines Finally Bearing Revenue
Investopedia
Thursday, December 10, 2009 - 7:40am
tags:
vaccines, swine flu, H1N1, Baxter International, GSK, Sanofi, Novartis, AstraZeneca
Pfizer rises as analyst expects dividend increase
Yahoo/AP
Thursday, December 10, 2009 - 7:40am
tags:
Pfizer, dividends
Watson Acquires Arrow
Yahoo/Zacks.com
Thursday, December 10, 2009 - 7:38am
tags:
Watson Pharmaceuticals, Arrow, M&A
Sizzling market heats up biotech buyout fever
Fierce Biotech
Wednesday, December 9, 2009 - 10:54am
tags:
biotech, M&A, Merrimack Pharmaceuticals, Hermes, Celgene, Glouchester Pharma
Sangamo drug looks promising in small strength trial
Fierce Biotech
Wednesday, December 9, 2009 - 10:36am
tags:
Sangamo BioSciences, ALS, drug trials
Gloucester Pharma Proves Single-Drug Model Can Work
WSJ Online
Wednesday, December 9, 2009 - 10:25am
tags:
Glouchester Pharma, Celgene, M&A, Istodax, non-Hodgkin's lymphoma
AstraZeneca's New Depression Drug Is a Cancelled Blood Pressure Medicine
BNET Pharma
Wednesday, December 9, 2009 - 10:23am
tags:
AstraZeneca, antidepressants, Targacept
Bristol-Myers $125 Million Plavix Accord Is Approved
Bloomberg
Wednesday, December 9, 2009 - 10:18am
tags:
Bristol-Myers Squibb, Plavix, settlements, Apotex, patents
FDA May Strengthen Antipsychotic Labels For Kids
Pharmalot
Wednesday, December 9, 2009 - 10:17am
tags:
antipsychotics, FDA, Eli Lilly, Zyprexa, AstraZeneca, Seroquel

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.